Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 known ✓ | Q13547 | 2/20 | 0.54 |
| ▸ | HDAC2 known ✓ | Q92769 | 2/20 | 0.54 |
| ▸ | ITGB3 known ✓ | P05106 | 4/20 | 0.52 |
| ▸ | ITGA2B known ✓ | P08514 | 4/20 | 0.52 |
| ▸ | DPP4 known ✓ | P27487 | 2/20 | 0.47 |
| ▸ | TGM2 | P21980 | 1/20 | 0.52 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.49 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.49 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.49 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.49 |
| ▸ | CTSL | P07711 | 4/20 | 0.48 |
| ▸ | TLR2 | O60603 | 1/20 | 0.47 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.47 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.47 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.47 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28627653 | 1.00 | HDAC1 (0.54) | HDAC1HDAC2TGM2ITGB3ITGA2B | |
| SCHEMBL16494584 | 0.99 | HDAC1 (0.55) | HDAC1HDAC2TGM2ITGB3ITGA2B | |
| SCHEMBL648254 | 0.99 | HDAC1 (0.55) | HDAC1HDAC2TGM2ITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL23723888 | 0.97 | HDAC1 (0.56) | HDAC1HDAC2TGM2ITGB3ITGA2B | |
| SCHEMBL8433172 | 0.90 | HDAC1 (0.65) | HDAC1HDAC2TGM2ITGB3ITGA2B | |
| SCHEMBL12091750 | 0.88 | TGM2 (0.57) | HDAC1HDAC2TGM2CTSLSIRT2 | |
| SCHEMBL2028970 | 0.88 | TGM2 (0.62) | HDAC1HDAC2TGM2DPP8SIRT2 | |
| SCHEMBL17737201 | 0.88 | ITGB3 (0.58) | ITGB3ITGA2BPRSS1PRSS2PRSS3 | |
| SCHEMBL12874110 | 0.87 | TGM2 (0.56) | HDAC1HDAC2TGM2CTSLSIRT2 | |
| SCHEMBL11867081 | 0.86 | CTSL (0.49) | HDAC1HDAC2TGM2CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12168030-B2 | Method for producing stable Actinidia deliciosa powder with high level bioactive actinidin enzyme | WAITAKI BIOSCIENCES (NZ) | 2024-12-17 | — | — | US | disclosed |
| EP-4099841-A1 | METHOD FOR PRODUCING STABLE ACTINIDIA DELICIOSA POWDER WITH HIGH LEVEL BIOACTIVE ACTINIDIN ENZYME | Waitaki Biosciences (NZ) | 2022-12-14 | — | — | EP | disclosed |
| CN-109259106-B | Method for improving mutton tenderness based on multiple fermentation | 福建农林大学 | 2022-05-10 | — | — | CN | disclosed |
| CN-109259105-B | Method for improving tenderness of duck meat based on multiple fermentation | 福建农林大学 | 2021-09-28 | — | — | CN | disclosed |
| CN-109259108-B | Method for improving beef tenderness based on multiple fermentation | 福建农林大学 | 2021-09-28 | — | — | CN | disclosed |
| CN-109259110-B | Method for improving goose tenderness based on multiple fermentation | 福建农林大学 | 2021-09-24 | — | — | CN | disclosed |
| US-8506945-B2 | Polymers with structure-defined functions | SMITH & NEPHEW, PLC. (GB) | 2013-08-13 | — | — | US | disclosed |
| US-20120225962-A1 | MOLECULARLY IMPRINTED POLYMERS, METHODS FOR THEIR PRODUCTION AND USES THEREOF | MONASH UNIVERSITY (AU) | 2012-09-06 | — | — | US | disclosed |
| US-20110300096-A1 | Polymers With Structure-Defined Functions | GREENER BRYAN (GB) | 2011-12-08 | — | — | US | disclosed |
| US-7955594-B2 | Maleic anhydride-methyl vinyl ether copolymers; polyamic acids; medical implant device, dressing, scaffold, or fluid adhesive for treatment or prophylaxis of wounds; enhanced activity of protease inhibitors and neurotransmitter drugs | SMITH & NEPHEW, PLC (GB) | 2011-06-07 | — | — | US | disclosed |
| US-20050032929-A1 | Polymers with structure-defined functions | SMITH & NEPHEW, PLC (GB) | 2005-02-10 | — | — | US | disclosed |
| EP-1436334-A1 | POLYMERS WITH STRUCTURE-DEFINED FUNCTIONS | Smith & Nephew PLC (GB) | 2004-07-14 | — | — | EP | disclosed |
| WO-2003027154-A1 | POLYMERS WITH STRUCTURE-DEFINED FUNCTIONS | SMITH & NEPHEW PLC (GB) | 2003-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120225962-A1 | MOLECULARLY IMPRINTED POLYMERS, METHODS FOR THEIR PRODUCTION AND USES THEREOF | MPI, IDE, NPEPPS | HDAC1 1188/4885HDAC2 2050/4885ITGB3 2806/4885 |
| US-20110300096-A1 | Polymers With Structure-Defined Functions | MMP1, MMP8, ADAM12 | HDAC1 688/4885HDAC2 1207/4885ITGB3 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.